We are live on ! Find out more
SEC

Seven Eight Capital Portfolio holdings

AUM $1.11B
1-Year Est. Return 29.48%
This Fund
S&P 500
This Quarter Est. Return
-6.56%
1 Year Est. Return
+29.48%
3 Year Est. Return
+13.61%
5 Year Est. Return
+117.69%
10 Year Est. Return
+239.1%
AUM
$855M
AUM Growth
+$250M
Cap. Flow
+$327M
Cap. Flow %
38.29%
Top 10 Hldgs %
13.1%
Holding
788
New
316
Increased
155
Reduced
106
Closed
211

Top Buys

Rank Stock Value
1
EW icon
Edwards Lifesciences
EW
+$13.6M
2
MRK icon
Merck
MRK
+$12.5M
3
ISRG icon
Intuitive Surgical
ISRG
+$11.1M
4
DOCU
DocuSign
DOCU
+$10.9M
5
PODD icon
Insulet
PODD
+$10.8M

Top Sells

Rank Stock Value
1
NDAQ icon
Nasdaq
NDAQ
+$7.26M
2
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$6.86M
3
INCY icon
Incyte
INCY
+$6.31M
4
FIS icon
Fidelity National Information Services
FIS
+$5.73M
5
ABBV icon
AbbVie
ABBV
+$4.95M

Sector Composition

Rank Sector Weight
1 Technology 20.41%
2 Consumer Discretionary 17.68%
3 Healthcare 16.13%
4 Industrials 12.13%
5 Financials 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ACAD icon
201
Acadia Pharmaceuticals
ACAD
$4.43B
$1.19M 0.14%
57,299
+3,575
+7% +$97.1K
TECK icon
202
Teck Resources
TECK
$29.6B
$1.19M 0.14%
27,669
-5,362
-16% -$222K
SAP icon
203
SAP
SAP
$212B
$1.19M 0.14%
+9,219
New +$1.25M
MGM icon
204
MGM Resorts International
MGM
$11.4B
$1.19M 0.14%
+32,336
New +$1.43M
MORF
205
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$1.17M 0.14%
+51,022
New +$2.68M
LBTYA icon
206
Liberty Global Class A
LBTYA
$3.62B
$1.17M 0.14%
68,050
+23,111
+51% +$417K
MHK icon
207
Mohawk Industries
MHK
$7.5B
$1.16M 0.14%
+13,485
New +$1.36M
CP icon
208
Canadian Pacific Kansas City
CP
$78.1B
$1.14M 0.13%
+15,357
New +$1.22M
GSK icon
209
GSK
GSK
$104B
$1.13M 0.13%
31,297
-10,753
-26% -$382K
GWW icon
210
W.W. Grainger
GWW
$65.3B
$1.12M 0.13%
1,625
-340
-17% -$246K
SLAB icon
211
Silicon Laboratories
SLAB
$7.17B
$1.12M 0.13%
+9,687
New +$1.34M
CGNX icon
212
Cognex
CGNX
$10.9B
$1.12M 0.13%
+26,406
New +$1.3M
ALGN icon
213
Align Technology
ALGN
$12.1B
$1.12M 0.13%
+3,663
New +$1.27M
HCA icon
214
HCA Healthcare
HCA
$87.2B
$1.11M 0.13%
+4,532
New +$1.24M
SWX icon
215
Southwest Gas
SWX
$6.47B
$1.11M 0.13%
+18,379
New +$1.17M
HIMS icon
216
Hims & Hers Health
HIMS
$6.43B
$1.11M 0.13%
176,182
-38,016
-18% -$283K
WM icon
217
Waste Management
WM
$90.6B
$1.11M 0.13%
+7,260
New +$1.17M
ABT icon
218
Abbott
ABT
$183B
$1.11M 0.13%
11,415
-12,960
-53% -$1.36M
GGG icon
219
Graco
GGG
$12.9B
$1.11M 0.13%
15,168
+4,948
+48% +$391K
MLCO icon
220
Melco Resorts & Entertainment
MLCO
$2.22B
$1.1M 0.13%
111,559
+65,659
+143% +$761K
BRC icon
221
Brady Corp
BRC
$4.44B
$1.1M 0.13%
+20,012
New +$1.03M
VRNS icon
222
Varonis Systems
VRNS
$4.59B
$1.1M 0.13%
35,975
+22,691
+171% +$670K
AMLX icon
223
Amylyx Pharmaceuticals
AMLX
$2.26B
$1.1M 0.13%
+59,891
New +$1.27M
PGR icon
224
Progressive
PGR
$123B
$1.09M 0.13%
7,831
-1,151
-13% -$151K
HTZ icon
225
Hertz
HTZ
$499M
$1.09M 0.13%
88,972
-110,446
-55% -$1.85M
7 8
9
10 11

Similar funds

PP
Pegasus Partners Mequon, Wisconsin $1.07B AUM 32.32% 1-Year Est. Return
ECM
Ensemble Capital Management San Francisco, California $1.18B AUM 41.81% 1-Year Est. Return
GCAC
Guardian Capital Advisors (Canada) Toronto, Ontario, Canada $1.02B AUM 25.29% 1-Year Est. Return
CAM
ClariVest Asset Management San Diego, California $980M AUM 60.89% 1-Year Est. Return
D
Diversified Wilmington, Delaware $911M AUM 31% 1-Year Est. Return
GFS
GYL Financial Synergies West Hartford, Connecticut $1.33B AUM 34.46% 1-Year Est. Return
FTIS
First Trust Investment Solutions Naples, Florida $888M AUM 34.3% 1-Year Est. Return
AIA
Alera Investment Advisors Deerfield, Illinois $851M AUM 29.76% 1-Year Est. Return

Seven Eight Capital's Q3 2023 Portfolio in Review

As of Q3 2023, Seven Eight Capital held 788 positions worth $855M, up 41% from $605M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Seven Eight Capital deployed $327M of net new capital in Q3 2023, opening 316 new positions and adding to 155 existing holdings. Its largest new stake was Merck: 115,677 shares worth $11.9M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was BioMarin Pharmaceuticals, an estimated $6.86M trimmed.

  • Seven Eight Capital's largest Q3 2023 buy was Merck: 115,677 shares worth $11.9M.
  • Seven Eight Capital added most to Edwards Lifesciences in Q3 2023, an estimated $13.6M increase.
  • Seven Eight Capital's biggest Q3 2023 reduction was BioMarin Pharmaceuticals, cutting an estimated $6.86M.
  • Seven Eight Capital fully exited Nasdaq in Q3 2023, selling an estimated $7.26M.
  • Seven Eight Capital's ten largest holdings make up 13% of its $855M portfolio in Q3 2023.
  • Seven Eight Capital opened 316 new positions and closed 211 in Q3 2023.
  • Seven Eight Capital's portfolio value rose 41% quarter-over-quarter to $855M.

Based on Seven Eight Capital's 13F filing for Q3 2023, filed 14 Nov 2023.